Study design
R3TA is a prospective, observational, self-report registry. There is no intervention, no assignment, and no protocol that tells anyone what to take. We record what participants report they are already experiencing.
Methodology
Observational stories are only useful when their limits are published alongside them. This page describes the design, the measures, the analysis plan, and the reasons R3TA findings must be read cautiously.
R3TA is a prospective, observational, self-report registry. There is no intervention, no assignment, and no protocol that tells anyone what to take. We record what participants report they are already experiencing.
Adults 18 or older who can give informed consent and are willing to complete a short standardized check-in on a regular cadence. Participation is self-selected, voluntary, and can be withdrawn at any time.
Weight and waist circumference, body composition where available, appetite/satiety/food-noise scales, energy, sleep, mood, activity, side effects, and treatment context including reported duration and titration history.
Individual records are private to the participant. Published views are de-identified and aggregated; any cell representing fewer than 5 contributors is suppressed before it is shown.
Reported measures are summarised at fixed timepoints (weeks 4, 12, 24, 36, 52) with medians, interquartile ranges, and counts. Attrition is reported alongside every figure. We do not impute missing data silently.
Self-selected samples, self-reported measurements, unverified product sourcing, no control group, and recall bias. R3TA results cannot establish safety or efficacy and should never be read as evidence that a compound works or is safe.
Regulatory note
GLP-3 is investigational and has not been approved by the FDA. R3TA is an independent research and education platform, is not affiliated with Eli Lilly, and does not supply, prescribe, direct, or encourage use of any compound. Protocol, consent, privacy, and adverse-event handling documents are subject to review by qualified regulatory and privacy counsel.